Azulis and Galia inject €15m into Bio-Clinic

Azulis invested via its MMF IV fund, an FCPR vehicle that closed on €225m in 2010. This is the fund's tenth investment to date. Both investors secured a minority stake, with the majority of Bio-Clinic shares remaining in the hands of the company's founder and manager Philippe Dabi.

Bio-Clinic will use the fresh capital to pursue its acquisitive growth strategy, with the aim of buying several independent laboratories in the Paris region.

Company
Established in 1995, Bio-Clinic operates 20 medical analysis laboratories in the Ile-de-France region. The group generates a €16m turnover.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Expansion
• Healthcare
• France
• Azulis Capital